Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Active ingredients:
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800818553

From
01 Jan 2019
to
31 Dec 2021

Status:
Current

Patient impact:
Critical

Availability:
Limited Availability

Reason:
Unexpected Increase in Demand

TGA Management Actions:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.